Is your teenager skipping breakfast? Why is that happening and what can you do? As per the data from the Centers for Disease Control and Prevention (CDC), which surveyed adolescent health and well-being found that 1 in 4 students in high school ate breakfast, which means 3 in 4 high school students are not eating their breakfast. This data is as per the 2023 survey.

What Did The Study Intend?

The report describes a 10-year long trend and also recent changes among the two years. The study delved deeper into adolescents' dietary, physical activity and sleep behaviors. The study is also based on a national youth risk behavior survey of a representative sample of students from grade nine to 12.

What Did The Study Find?

The study found that while high school students drank slightly less soda and sports drinks and consumed more water, other healthy eating habits declined. In 2023, only 27% of students ate breakfast every day in the past week. The numbers were even lower for female students, with just 22% eating breakfast daily, compared to 32% of male students. Boys were also more likely to eat fruits and vegetables daily and drink water at least three times a day. Poor mental health and lack of physical activity have also been linked to skipping breakfast.

The other findings included a survey across 10-year period, where a decrease in the percentage of students eating fruits from 65% to 55%, eating vegetables, from 61% to 58%, and having breakfast daily from 38% to 27% was noted.

However, there was a positive trend among this, which was in children drinking plain water at least three times a day, which increased from 49% to 54% from when the survey began in 2015.. There were fewer students who also said that they drank soda in 2023 than in 2013. On an average, in 2013, around 22% students avoided soda, whereas in 2023, 31% students avoided it.

The report also emphasized that a healthy diet, along with daily physical activity and sufficient sleep further contributes to a healthy lifestyle. “The 10-year trends from 2013 to 2023 also show a decline in healthy dietary, physical activity, and sleep behaviors,” the survey reported.

Why Do High School Students Skip Breakfast?

While there is no one straightforward answer to it, psychologists and those who study children, believe that for many high school going kids, it is the easiest time to skip a meal. This is because they are caught between rushing to school, or not just that hungry in the morning. So for them, to sit down to have a breakfast may seem hassle and something they would have to take time out from their busy schedule. They at this age also prioritize their extra-curricular activities.

There has also been a shift in their circadian rhythm, and most teens cannot fall asleep before 11 pm, or even at midnight. Which means they wake up tired and struggle to do things right in the morning, which is why they choose to skip breakfast or give extra minutes to any other activities.

There is of course another, more popular reason, to lose weight. While experts and studies, like the one published in the Journal of Nutrition that found skipping breakfast leads to higher levels of hunger hormones, the students still feel the need to do this. However, it could lead to a slow metabolism, prompt the body to conserve energy and burn fewer calories, weight gain and deprive yo off the essential nutrients like calcium, iron, and vitamin D.

Without a morning breakfast, your blood sugar might drop too, which can increase irritability and stress, along with including the risk of depression in teenage.

Russia has told the World Health Organization (WHO) that no cases of plague have been recorded in Irkutsk, the Siberian city that has sparked international headlines after a laboratory worker from an anti-plague research institute died after suspected exposure to pneumonic plague infection.

The WHO said Russian authorities responded on October 6 to its request for information under the International Health Regulations (IHR), saying the woman’s illness had initially appeared to be a typical acute respiratory viral infection.

Russia also reported that no plague case had been recorded in Irkutsk, either in the woman or among her contacts.

However, the exact cause of the woman’s death still remains unclear.

Russia Says No Plague Cases In Irkutsk

The WHO recently said, “WHO is aware of media reports that a laboratory worker in Irkutsk oblast, in the Russian Federation, died of suspected pneumonic plague, and that nearly 200 of her contacts were under medical observation and being tested."

“On 3 October, WHO asked the Russian authorities under the International Health Regulations (IHR) for any further information they had, so we could assess the risk.”

The WHO said Russia reported that “no case of plague has been recorded in Irkutsk, either in her or in anyone else.”

Adding further, the health body said, "They informed WHO that an epidemiological investigation had been conducted, preventive and control measures implemented, and identified contacts placed under medical observation and tested. They reported that no high-threat pathogens had been detected among the contacts and that medical observation of all identified contacts had been completed."

But the agency is still seeking an answer on what caused the fatal pneumonia as the lab worker's death still remains a mystery.

It said, “WHO has remained in contact with the Russian health authorities and has offered technical support. WHO has requested further information to clarify the cause of the severe pneumonia, the pathogen that prompted the public health measures, and media reports of a second employee with pneumonia of undetermined cause.”

Also read: Russia Plague Scare: What Black Death and Anthrax Outbreaks Teach Us About Lab Safety

Lab Worker's Death Still Remains Unexplained

The 28-year-old woman, identified by Russian media as Darya Shipilova, worked at the Irkutsk Anti-Plague Research Institute of Siberia and the Far East. She died on October 2 after developing severe pneumonia of "unknown origin", according to Russian authorities.

Her death sparked precautionary measures including quarantine. According to reports, around 200 people who had contact with her placed under medical observation. Russian health authorities said testing of those contacts found no dangerous infectious-disease pathogens. Some contacts reportedly tested positive for COVID-19 or rhinovirus.

Reports circulating on social media claimed she may have been infected after a laboratory accident involving Yersinia pestis, the bacterium that causes plague. Russian authorities have rejected the laboratory-accident theory, and there is currently no independent evidence confirming that such an incident occurred.

Also read: Russia Plague Scare: Is Pneumonic Plague Deadlier Than Bubonic & Septicemic Plague?

What Could Confirm Plague?

Javier Pizarro-Cerda, head of the Yersinia Research Unit at the Institut Pasteur in Paris, told CNBC that he was “very surprised” by the reported death because laboratories handling plague generally use strict protective measures.

“You work with a full body suit. You work with masks. You work with gloves. So even if you break a tube, normally you should be protected,” he said.

Pizarro-Cerda also said Russia has a plague vaccine, although he described its protection as low and transient compared with standards elsewhere.

Pizarro-Cerda said plague testing can be performed rapidly and that an autopsy should provide evidence if the woman had pulmonary plague.

The laboratory worker reportedly died on October 2, giving authorities several days to conduct diagnostic tests. Still, there is no confirmation that pneumonic plague caused her death or that a laboratory accident occurred.

Key questions remain whether Yersinia pestis was detected, whether there was evidence of laboratory exposure, and whether genetic testing can establish the source of any infection.

The suspected plague is still being investigated. The concern stems partly from the nature of the institute where Shipilova worked. The facility studies dangerous pathogens, including plague, in a region where the disease occurs naturally among wild animals.

Pneumonic plague is the most severe form of plague because it affects the lungs and can spread between people through respiratory droplets. Plague is treatable with antibiotics when diagnosed and treated promptly.

The WHO has assessed the public-health risk as moderate-to-low for Irkutsk, low for Russia overall and very low for the WHO European region.

Aspirin has long been studied for its role in colorectal cancer prevention. But a new trial suggests that when aspirin is started may be of more importance compared to whether it is used at all.

In the latest study, researchers discovered that aspirin did not prevent cancer recurrence or improve survival in people whose colorectal cancer had already spread to the liver.

The study, published in The Lancet Gastroenterology & Hepatology, is based on 428 patients who were treated for colorectal cancer liver metastases at 14 hospitals across Norway, Sweden and Denmark. Participants were randomly assigned to receive either 160 mg of aspirin or a placebo every day for up to three years.

Aspirin Did Not Help After Cancer Had Spread

After treatment for their liver metastases, patients taking aspirin did not have better results than others who took placebo.

In fact, after three years, 76% of people in the aspirin group were alive compared to 85% in the placebo group. Researchers say that the overall survival was a secondary outcome. They also said that the trial was not designed to provide a definitive answer about that measure.

Serious adverse events were also more common with aspirin, occurring in 8% of the aspirin group compared with 2% of the placebo group. Reported complications included heart attacks, nosebleeds, duodenal ulcers and cerebral haemorrhage.

“Although aspirin has been shown to reduce recurrence rates in patients who have undergone surgery for a primary tumour in the colon or rectum, its effects still need to be evaluated in the specific patient group for which it is intended, in this case patients with colorectal cancer that has spread to the liver. We found no clear benefit in this group, while serious adverse events were more common,” said Ernesto Sparrelid, adjunct professor at Karolinska Institutet.

Also read: Why Someone Days Away From Death May Start To See Loved Ones: End-Of-Life Doctor & Neurologist Explain

Aspirin Works In Earlier-Stage Cancer

The new findings contrast with results from the ALASCCA trial, which found that low-dose aspirin reduced colorectal cancer recurrence in patients whose tumours had alterations in genes related to PI3K.

In that trial, the three-year recurrence rate was 7.7% with aspirin versus 14.1% with placebo among patients with specific PIK3CA alterations.

This suggests that aspirin may not be a universal anti-cancer drug. Its benefit may largely depend on the biology of the tumour and how advanced the cancer stage is.

“The anticancer effects of aspirin may depend on the biological and clinical context,” said co-principal investigator Kjetil Taskén of the University of Oslo.

Another possible explanation is that aspirin's anti-inflammatory and anti-platelet effects may interfere with some of the biological processes involved in early tumour growth and recurrence. But once cancer has already spread, particularly to the liver, the biology becomes more complex.

“Aspirin is a well-established, inexpensive and widely available drug, and there is considerable interest in whether it can also reduce the risk of cancer recurrence,” said lead author Sheraz Yaqub of the University of Oslo. “Our findings demonstrate why such treatments must be tested in rigorous randomized trials before being adopted for new patient populations.”

Also read: Trump Says He ‘Psychologically’ Needs To Pop Aspirin Every Day: But Is It Actually Safe?

Trump’s Recent Comments About Aspirin

The findings come just days after President Donald Trump disclosed that he takes aspirin every day, adding that prefers a full-strength tablet.

At an October 3 rally in Ohio, Trump said, “I take an aspirin a day. I don't know if it works, but psychologically I need it.” He also said doctors had wanted him to switch to a lower dose, but that he preferred the larger tablet.

Trump's comments have reignited discussion about daily aspirin use, but they should not be interpreted as medical advice.

Aspirin may reduce clot formation, but it can also increase the risk of serious bleeding. The American Heart Association says routine daily aspirin is generally not recommended for healthy adults without cardiovascular disease unless advised by a healthcare professional.

And the new cancer findings add another reason not to assume that taking aspirin routinely will prevent cancer or improve outcomes after a diagnosis.

The suspected pneumonic plague case in Russia has revived memories of the Black Death and the 1979 Sverdlovsk anthrax outbreak.

While Russia has denied any plague outbreak, the death of a young laboratory worker and reports of nearly 200 people being placed under medical observation have raised questions about laboratory safety and what may have happened.

Moscow told the World Health Organization (WHO) that no plague cases have been detected in Irkutsk and that the deceased woman’s contacts tested negative for dangerous pathogens. COVID-19 and rhinovirus were detected in some people under observation.

Russia Says No Plague Cases Detected

Russian authorities told the WHO that there was “no case of this dangerous disease” in Irkutsk, WHO spokesperson Christian Lindmeier said at a Geneva briefing.

Russia also said contacts of the deceased tested negative for dangerous infectious pathogens.

The circumstances of the death have nevertheless raised questions about laboratory safety and possible pathogen exposure.

Also read: Russia Plague Scare: Could It Trigger A New Pandemic? Experts Explain

From Black Death to Pneumonic Plague

The Black Death swept across Eurasia and North Africa between 1346 and 1353, killing an estimated 30% to 60% of Europe’s population.

It was caused by Yersinia pestis, the same bacterium responsible for plague today. The pandemic was primarily associated with bubonic plague, although pneumonic plague also occurred.

Bubonic plague is mainly spread through infected flea bites, while pneumonic plague affects the lungs and can spread between people through respiratory droplets during close contact. Modern antibiotics can treat plague, particularly when given early.

The 1979 Sverdlovsk Anthrax Outbreak

The circumstances surrounding the Russian lab worker’s death have also revived memories of the anthrax outbreak in Sverdlovsk, then part of the Soviet Union, in April and May 1979.

Soviet authorities initially blamed contaminated meat, while US officials attributed the outbreak to anthrax spores accidentally released from a military microbiology facility.

The distribution of human and animal cases along a path extending from the facility was consistent with an airborne release.

The incident remains an important example of the consequences of an accidental biological-agent release.

Why Has the Russia Case Raised Questions?

Read More: Russia Plague Scare: Is Pneumonic Plague Deadlier Than Bubonic & Septicemic Plague?

The cause of the laboratory worker’s death and the circumstances of any possible exposure remain unclear.

The reported quarantine of nearly 200 people has also raised questions about the scale of the response.

Dr. Ashish Jha, former dean of Brown University’s School of Public Health, said the case had raised several “red flags.”

He questioned whether a laboratory worker handling plague would have been vaccinated or received antibiotics promptly after a suspected exposure, and why so many people were placed under quarantine.

Jha also pointed to Russia’s history of biological weapons research and expressed concern about the lack of information from Russian authorities.

There is currently no evidence, however, that the death was linked to a biological weapons programme or that a laboratory leak occurred.

How Safe Are Plague Laboratories?

Javier Pizarro-Cerda, head of the Yersinia Research Unit at the Institut Pasteur in Paris, told CNBC that he was “very surprised” by the reported death because laboratories handling plague generally use strict protective measures.

“You work with a full body suit. You work with masks. You work with gloves. So even if you break a tube, normally you should be protected,” he said.

Pizarro-Cerda also said Russia has a plague vaccine, although he described its protection as low and transient compared with standards elsewhere.

What Could Confirm Plague?

Pizarro-Cerda said plague testing can be performed rapidly and that an autopsy should provide evidence if the woman had pulmonary plague.

The laboratory worker reportedly died on October 2, giving authorities several days to conduct diagnostic tests.

Still, there is no confirmation that pneumonic plague caused her death or that a laboratory accident occurred.

Key questions remain whether Yersinia pestis was detected, whether there was evidence of laboratory exposure, and whether genetic testing can establish the source of any infection.